Development of an in vitro assay and demonstration of Plasmodium berghei liver- Stage inhibition by TRAP-specific CD8+ T Cells

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Longley, Rhea J ^a,b,c,d   Bauza, Karolis ^a   Ewer, Katie J ^a   Hill, Adrian V S ^a   Spencer, Alexandra J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c MAHIDOL UNIVERSITY   (Thailand)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; PROTOZOAL PROTEIN; PROTOZOAL VACCINE; THROMBOSPONDIN RELATED ADHESION PROTEIN VACCINE; UNCLASSIFIED DRUG; MALARIA VACCINE; PARASITE ANTIGEN; THROMBOSPONDIN-RELATED ADHESIVE PROTEIN, PROTOZOAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SCREENING; FEASIBILITY STUDY; FEMALE; FLOW CYTOMETRY; GROWTH INHIBITION; IMMUNE RESPONSE; IN VITRO STUDY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PARASITE IDENTIFICATION; PLASMODIUM (LIFE CYCLE STAGE); PLASMODIUM BERGHEI; PROCESS DEVELOPMENT; PROTEIN EXPRESSION; SPLEEN CELL; SPOROZOITE; VACCINATION; ANIMAL; C57BL MOUSE; CELL LINE; CYTOLOGY; GENETICS; HUMAN; IMMUNOLOGY; LIVER; MALARIA; PARASITOLOGY; PATHOGENICITY; SPLEEN;

PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM PARASITES;

ANIMALS; ANTIGENS, PROTOZOAN; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; FEMALE; GREEN FLUORESCENT PROTEINS; HUMANS; IN VITRO TECHNIQUES; LIVER; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED C57BL; PLASMODIUM BERGHEI; PROTOZOAN PROTEINS; SPLEEN; SPOROZOITES;

EID: 84926334122     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119880     Document Type: Article

References (53)

1. World Malaria Report. Geneva, Switzerland: World Health Organisation, 2012.
2. O'Hara GA, Duncan CJ, Ewer KJ, Collins KA, Elias SC, Halstead FD, et al. Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector. The Journal of infectious diseases. 2012; 205(5):772-81. Epub 2012/01/26. doi: 10.1093/infdis/jir850 PMID: 22275401; PubMed Central PMCID: PMCPMC3274376.
3. Ewer KJ, O'Hara GA, Duncan CJ, Collins KA, Sheehy SH, Reyes-Sandoval A, et al. Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation. Nature communications. 2013; 4:2836. Epub 2013/11/29. doi: 10.1038/ncomms3836 PMID: 24284865; PubMed Central PMCID: PMCPMC3868203.
4. Ghosh AK, Devenport M, Jethwaney D, Kalume DE, Pandey A, Anderson VE, et al. Malaria parasite invasion of the mosquito salivary gland requires interaction between the Plasmodium TRAP and the Anopheles saglin proteins. PLoS pathogens. 2009; 5(1):e1000265. Epub 2009/01/17. doi: 10.1371/ journal.ppat.1000265 PMID: 19148273; PubMed Central PMCID: PMCPMC2613030.
5. Kappe S, Bruderer T, Gantt S, Fujioka H, Nussenzweig V, Menard R. Conservation of a gliding motility and cell invasion machinery in Apicomplexan parasites. The Journal of cell biology. 1999; 147(5):937- 44. Epub 1999/12/01. PMID: 10579715; PubMed Central PMCID: PMCPMC2169348.
6. Muller HM, Scarselli E, Crisanti A. Thrombospondin related anonymous protein (TRAP) of Plasmodium falciparum in parasite-host cell interactions. Parassitologia. 1993; 35 Suppl:69-72. Epub 1993/07/01. PMID: 8233617.
7. Pradel G, Garapaty S, Frevert U. Proteoglycans mediate malaria sporozoite targeting to the liver. Molecular microbiology. 2002; 45(3):637-51. Epub 2002/07/26. PMID: 12139612.
8. Sultan AA, Thathy V, Frevert U, Robson KJ, Crisanti A, Nussenzweig V, et al. TRAP is necessary for gliding motility and infectivity of plasmodium sporozoites. Cell. 1997; 90(3):511-22. Epub 1997/08/08. PMID: 9267031.
9. Reyes-Sandoval A, Rollier CS, Milicic A, Bauza K, Cottingham MG, Tang CK, et al. Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity. Molecular therapy: the journal of the American Society of Gene Therapy. 2012; 20 (8):1633-47. Epub 2012/02/23. doi: 10.1038/mt.2012.25 PMID: 22354374; PubMed Central PMCID: PMCPMC3412496.
10. Reyes-Sandoval A, Sridhar S, Berthoud T, Moore AC, Harty JT, Gilbert SC, et al. Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei. European journal of immunology. 2008; 38(3):732-41. Epub 2008/02/13. doi: 10.1002/eji.200737672 PMID: 18266272.
11. Bauza K, Malinauskas T, Pfander C, Anar B, Jones EY, Billker O, et al. Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites. Infection and immunity. 2014; 82(3):1277-86. Epub 2014/01/01. doi: 10.1128/iai.01187-13 PMID: 24379295; PubMed Central PMCID: PMCPMC3957994.
12. Brahimi K, Badell E, Sauzet JP, BenMohamed L, Daubersies P, Guerin-Marchand C, et al. Human antibodies against Plasmodium falciparum liver-stage antigen 3 cross-react with Plasmodium yoelii preery-throcytic- stage epitopes and inhibit sporozoite invasion in vitro and in vivo. Infection and immunity. 2001; 69(6):3845-52. Epub 2001/05/12. doi: 10.1128/iai.69.6.3845-3952.2001 PMID: 11349050; PubMed Central PMCID: PMCPMC98406.
13. Hollingdale MR, Appiah A, Leland P, do Rosario VE, Mazier D, Pied S, et al. Activity of human volunteer sera to candidate Plasmodium falciparum circumsporozoite protein vaccines in the inhibition of sporozoite invasion assay of human hepatoma cells and hepatocytes. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1990; 84(3):325-9. Epub 1990/05/01. PMID: 2175464.
14. Hollingdale MR, Ballou WR, Aley SB, Young JF, Pancake S, Miller LH, et al. Plasmodium falciparum: elicitation by peptides and recombinant circumsporozoite proteins of circulating mouse antibodies inhibiting sporozoite invasion of hepatoma cells. Experimental parasitology. 1987; 63(3):345-51. Epub 1987/06/01. PMID: 2438152.
15. Hollingdale MR, Nardin EH, Tharavanij S, Schwartz AL, Nussenzweig RS. Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies. Journal of immunology (Baltimore, Md: 1950). 1984; 132(2):909-13. Epub 1984/02/01. PMID: 6317752.
16. Mazier D, Mellouk S, Beaudoin RL, Texier B, Druilhe P, Hockmeyer W, et al. Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro. Science (New York, NY). 1986; 231(4734):156-9. Epub 1986/01/10. PMID: 3510455.
17. Mellouk S, Berbiguier N, Druilhe P, Sedegah M, Galey B, Yuan L, et al. Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites. Bulletin of the World Health Organization. 1990; 68 Suppl:52-9. Epub 1990/01/01. PMID: 2094592; PubMed Central PMCID: PMCPMC2393043.
18. Finney OC, Keitany GJ, Smithers H, Kaushansky A, Kappe S, Wang R. Immunization with genetically attenuated P. falciparum parasites induces long-lived antibodies that efficiently block hepatocyte invasion by sporozoites. Vaccine. 2014; 32(19):2135-8. Epub 2014/03/04. doi: 10.1016/j.vaccine.2014.02. 055 PMID: 24582635.
19. Zou X, House BL, Zyzak MD, Richie TL, Gerbasi VR. Towards an optimized inhibition of liver stage development assay (ILSDA) for Plasmodium falciparum. Malaria journal. 2013; 12:394. Epub 2013/11/07. doi: 10.1186/1475-2875-12-394 PMID: 24191920; PubMed Central PMCID: PMCPMC3831258.
20. Hoffman SL, Isenbarger D, Long GW, Sedegah M, Szarfman A, Waters L, et al. Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science (New York, NY). 1989; 244(4908):1078-81. Epub 1989/06/02. PMID: 2524877.
21. Renia L, Grillot D, Marussig M, Corradin G, Miltgen F, Lambert PH, et al. Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages. Journal of immunology (Baltimore, Md: 1950). 1993; 150(4):1471-8. Epub 1993/02/15. PMID: 7679428.
22. Renia L, Marussig MS, Grillot D, Pied S, Corradin G, Miltgen F, et al. In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide. Proceedings of the National Academy of Sciences of the United States of America. 1991; 88(18):7963-7. Epub 1991/09/15. PMID: 1680235; PubMed Central PMCID: PMCPMC52425.
23. Weiss WR, Mellouk S, Houghten RA, Sedegah M, Kumar S, Good MF, et al. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. The Journal of experimental medicine. 1990; 171(3):763-73. Epub 1990/03/01. PMID: 1689762; PubMed Central PMCID: PMCPMC2187765.
24. Trimnell A, Takagi A, Gupta M, Richie TL, Kappe SH, Wang R. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes. Journal of immunology (Baltimore, Md: 1950). 2009; 183(9):5870-8. Epub 2009/10/09. doi: 10. 4049/jimmunol.0900302 PMID: 19812194.
25. Hafalla JC, Bauza K, Friesen J, Gonzalez-Aseguinolaza G, Hill AV, Matuschewski K. Identification of targets of CD8(+) T cell responses to malaria liver stages by genome-wide epitope profiling. PLoS pathogens. 2013; 9(5):e1003303. Epub 2013/05/16. doi: 10.1371/journal.ppat.1003303 PMID: 23675294; PubMed Central PMCID: PMCPMC3649980.
26. Franke-Fayard B, Trueman H, Ramesar J, Mendoza J, van der Keur M, van der Linden R, et al. A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Molecular and biochemical parasitology. 2004; 137(1):23-33. Epub 2004/07/29. doi: 10.1016/j.molbiopara.2004.04.007 PMID: 15279948.
27. Grimm CF, Ortmann D, Mohr L, Michalak S, Krohne TU, Meckel S, et al. Mouse alpha-fetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice. Gastroenterology. 2000; 119(4):1104-12. Epub 2000/10/21. PMID: 11040197.
28. Harimoto H, Shimizu M, Nakagawa Y, Nakatsuka K, Wakabayashi A, Sakamoto C, et al. Inactivation of tumor-specific CD8(+) CTLs by tumor-infiltrating tolerogenic dendritic cells. Immunology and cell biology. 2013; 91(9):545-55. Epub 2013/09/11. doi: 10.1038/icb.2013.38 PMID: 24018532; PubMed Central PMCID: PMCPMC3806489.
29. Zimmermann M, Flechsig C, La Monica N, Tripodi M, Adler G, Dikopoulos N. Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes. Journal of hepatology. 2008; 48(1):51-60. Epub 2007/11/14. doi: 10.1016/j.jhep.2007.08.008 PMID: 17998148.
30. Sinnis P, De La Vega P, Coppi A, Krzych U, Mota MM. Quantification of sporozoite invasion, migration, and development by microscopy and flow cytometry. Methods in molecular biology (Clifton, NJ). 2013; 923:385-400. Epub 2012/09/20. doi: 10.1007/978-1-62703-026-7-27 PMID: 22990793; PubMed Central PMCID: PMCPMC3951895.
31. Mota MM, Pradel G, Vanderberg JP, Hafalla JC, Frevert U, Nussenzweig RS, et al. Migration of Plasmodium sporozoites through cells before infection. Science (New York, NY). 2001; 291(5501):141-4. Epub 2001/01/06. doi: 10.1126/science.291.5501.141 PMID: 11141568.
32. Prudencio M, Rodrigues CD, Ataide R, Mota MM. Dissecting in vitro host cell infection by Plasmodium sporozoites using flow cytometry. Cellular microbiology. 2008; 10(1):218-24. Epub 2007/08/19. doi: 10.1111/j.1462-5822.2007.01032.x PMID: 17697130.
33. Cottingham MG, Carroll F, Morris SJ, Turner AV, Vaughan AM, Kapulu MC, et al. Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors. Biotechnology and bioengineering. 2012; 109(3):719-28. Epub 2012/01/19. doi: 10.1002/bit.24342 PMID: 22252512.
34. Draper SJ, Moore AC, Goodman AL, Long CA, Holder AA, Gilbert SC, et al. Effective induction of hightiter antibodies by viral vector vaccines. Nature medicine. 2008; 14(8):819-21. Epub 2008/07/29. doi: 10.1038/nm.1850 PMID: 18660818.
35. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer M, et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. Journal of immunological methods. 2003; 281(1-2):65-78. Epub 2003/10/29. PMID: 14580882.
36. Silvie O, Franetich JF, Boucheix C, Rubinstein E, Mazier D. Alternative invasion pathways for Plasmodium berghei sporozoites. International journal for parasitology. 2007; 37(2):173-82. Epub 2006/11/23. doi: 10.1016/j.ijpara.2006.10.005 PMID: 17112526.
37. O'Doherty U, Swiggard WJ, Malim MH. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. Journal of virology. 2000; 74(21):10074-80. Epub 2000/10/12. PMID: 11024136; PubMed Central PMCID: PMCPMC102046.
38. Scanlan PM, Tiwari V, Bommireddy S, Shukla D. Spinoculation of heparan sulfate deficient cells enhances HSV-1 entry, but does not abolish the need for essential glycoproteins in viral fusion. Journal of virological methods. 2005; 128(1-2):104-12. Epub 2005/05/24. doi: 10.1016/j.jviromet.2005.04.008 PMID: 15908019.
39. Khusmith S, Sedegah M, Hoffman SL. Complete protection against Plasmodium yoelii by adoptive transfer of a CD8+ cytotoxic T-cell clone recognizing sporozoite surface protein 2. Infection and immunity. 1994; 62(7):2979-83. Epub 1994/07/01. PMID: 8005684; PubMed Central PMCID: PMCPMC302907.
40. Rodrigues MM, Cordey AS, Arreaza G, Corradin G, Romero P, Maryanski JL, et al. CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. International immunology. 1991; 3(6):579-85. Epub 1991/06/01. PMID: 1716146.
41. Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, Zavala F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature. 1989; 341(6240):323-6. Epub 1989/09/28. doi: 10.1038/341323a0 PMID: 2477703.
42. Weiss WR, Berzofsky JA, Houghten RA, Sedegah M, Hollindale M, Hoffman SL. A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei. Journal of immunology (Baltimore, Md: 1950). 1992; 149(6):2103-9. Epub 1992/09/15. PMID: 1517574.
43. Doolan DL, Hoffman SL. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model. Journal of immunology (Baltimore, Md: 1950). 1999; 163(2):884-92. Epub 1999/07/08. PMID: 10395683.
44. Seguin MC, Klotz FW, Schneider I, Weir JP, Goodbary M, Slayter M, et al. Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells. The Journal of experimental medicine. 1994; 180(1):353-8. Epub 1994/07/01. PMID: 7516412; PubMed Central PMCID: PMCPMC2191552.
45. Tarun AS, Dumpit RF, Camargo N, Labaied M, Liu P, Takagi A, et al. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. The Journal of infectious diseases. 2007; 196(4):608-16. Epub 2007/07/13. doi: 10.1086/519742 PMID: 17624848.
46. Weiss WR, Sedegah M, Beaudoin RL, Miller LH, Good MF. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proceedings of the National Academy of Sciences of the United States of America. 1988; 85(2):573-6. Epub 1988/01/01. PMID: 2963334; PubMed Central PMCID: PMCPMC279593.
47. Karnasuta C, Pavanand K, Chantakulkij S, Luttiwongsakorn N, Rassamesoraj M, Laohathai K, et al. Complete development of the liver stage of Plasmodium falciparum in a human hepatoma cell line. The American journal of tropical medicine and hygiene. 1995; 53(6):607-11. Epub 1995/12/01. PMID: 8561262.
48. Sattabongkot J, Yimamnuaychoke N, Leelaudomlipi S, Rasameesoraj M, Jenwithisuk R, Coleman RE, et al. Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. The American journal of tropical medicine and hygiene. 2006; 74(5):708-15. Epub 2006/05/12. PMID: 16687667.
49. Mazier D, Beaudoin RL, Mellouk S, Druilhe P, Texier B, Trosper J, et al. Complete development of hepatic stages of Plasmodium falciparum in vitro. Science (New York, NY). 1985; 227(4685):440-2. Epub 1985/01/25. PMID: 3880923.
50. March S, Ng S, Velmurugan S, Galstian A, Shan J, Logan DJ, et al. A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax. Cell host & microbe. 2013; 14 (1):104-15. Epub 2013/07/23. doi: 10.1016/j.chom.2013.06.005 PMID: 23870318; PubMed Central PMCID: PMCPMC3780791.
51. Talman AM, Blagborough AM, Sinden RE. A Plasmodium falciparum strain expressing GFP throughout the parasite's life-cycle. PloS one. 2010; 5(2):e9156. Epub 2010/02/18. doi: 10.1371/journal.pone. 0009156 PMID: 20161781; PubMed Central PMCID: PMCPMC2819258.
52. Vaughan AM, Mikolajczak SA, Camargo N, Lakshmanan V, Kennedy M, Lindner SE, et al. A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle. Molecular and biochemical parasitology. 2012; 186(2):143-7. Epub 2012/10/31. doi: 10.1016/j. molbiopara.2012.10.004 PMID: 23107927.
53. Sheehy SH, Spencer AJ, Douglas AD, Sim BK, Longley RJ, Edwards NJ, et al. Optimising Controlled Human Malaria Infection Studies Using Cryopreserved Parasites Administered by Needle and Syringe. PloS one. 2013; 8(6):e65960. Epub 2013/07/05. doi: 10.1371/journal.pone.0065960 PMID: 23823332; PubMed Central PMCID: PMCPMC3688861.